Slovenia - English - HMA (Heads of Medicines Agencies)

laboratorios hipra s. a. - clostridium novyi 50 >=%er120, clostridium perfringens type c toxoid 35 >=%er25, escherichia coli 55 >=%er70, escherichia coli 65 >=%er60, escherichia coli 78 >=%er70, escherichia coli 79 >=%er50, escherichia coli 80 >=%er25 - suspension for injection - pigs food - escherichia + clostridium

United Kingdom - English - HMA (Heads of Medicines Agencies)

laboratorios hipra s. a. - clostridium novyi 50 >=%er120, clostridium perfringens type c toxoid 35 >=%er25, escherichia coli 55 >=%er70, escherichia coli 65 >=%er60, escherichia coli 78 >=%er70, escherichia coli 79 >=%er50, escherichia coli 80 >=%er25 - suspension for injection - pigs food - escherichia + clostridium

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios hipra s.a. - clostridium novyi toxoid ; clostridium perfringens type c toxoid ; escherichia coli f4ab fimbrial adhesin ; eschericia coli lt-enterotoxoïd ; escherichia coli f4ac fimbrial adhesin ; escherichia coli f5 fimbrial adhesin ; escherichia coli f6 fimbrial adhesin - suspension for injection - escherichia

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - clostridium perfringens, escherichia coli - suspension for injection - inactivated bacterial vaccine - pigs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

cz veterinaria s.a. - clostridium perfringens, escherichia coli - emulsion for injection - inactivated bacterial vaccine - pigs

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - lt toxoid and e. coli antigens, k88ab, k88ac, k99 and 987p - emulsion for injection - porcine - immunological - inactivated vaccine

European Union - English - EMA (European Medicines Agency)

elanco gmbh - live non-pathogenic escherichia coli o141:k94 (f18ac) and o8:k87 (f4ac) - immunologicals for suidae, live bacterial vaccines - pigs - for active immunisation of pigs from 18 days of age against enterotoxigenic f4-positive and f18-positive escherichia coli in order to reduce the incidence of moderate to severe post-weaning e. coli diarrhoea (pwd) in infected pigs and to reduce the faecal shedding of enterotoxigenic f4-positive and f18-positive e. coli from infected pigs.

Philippines - English - FDA (Food And Drug Administration)

elanco philippines, inc.; distributor: elanco philippines, inc. - live escherichia coli (e. coli) vaccine (vet.) - freeze-dried powder for oral suspension - live non-pathogenic escherichia coli (f4ac) (08:k87 strain)......... >1.3 x 10^x.0 cfu (f18ac) (o141:k94 strain) ........>2.8 x 10^x.0 cfu cfu-colony forming unit

United States - English - NLM (National Library of Medicine)

preferred pharmaeuticals inc. - lamotrigine (unii: u3h27498ks) (lamotrigine - unii:u3h27498ks) - adjunctive therapy: lamotrigine is indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older: monotherapy: lamotrigine is indicated for conversion to monotherapy in adults (aged 16 years and older) with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (aed). safety and effectiveness of lamotrigine have not been established (1) as initial monotherapy; (2) for conversion to monotherapy from aeds other than carbamazepine, phenytoin, phenobarbital, primidone, or valproate; or (3) for simultaneous conversion to monotherapy from 2 or more concomitant aeds. lamotrigine is indicated for the maintenance treatment of bipolar i disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy [see clinical studies (14.2)] . limitations of use: treatment of acute manic or